A Study to Evaluate the Safety, Tolerability, and Weight Loss Efficacy of K-757 Alone and in Combination With K-833
Condition: Obesity Interventions: Drug: K-757 and K-833; Drug: K-757 and matching placebo to K-833; Drug: Matching placebo to K-757 and matching placebo to K-833 Sponsor: Kallyope Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials
The Effect of Dapagliflozin on Weight Loss in Obese Adults Without Diabetes
Conditions: Obesity; Dapagliflozin Adverse Reaction; Weight Loss; Effect of Drug Intervention: Drug: Dapagliflozin 10mg Tab Sponsor: Oman Ministry of Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
